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ABSTRACT
￿
Our earlier studies indicated that the mitotic factors, which induce germinal vesicle
breakdown and chromosome condensation when injected into fully grown Xenopus oocytes,
are preferentially associated with metaphase chromosomes and that they bind to chromatin
as soon as they are synthesized during the G2 phase. In this study, we attempted to determine
the fate of these factors as the cell completes mitosis and enters G, . Extracts from HeLa cells
at different points during G,, S, and G2 periods were mixed with mitotic extracts in various
proportions, incubated, and then injected into Xenopus oocytes to determine their maturation-
promoting activity. The maturation-promoting activity of the mitotic extracts was neutralized
by extracts of G, cells during all stages of G, but not by those of late S and G2 phase cells.
Extracts of quiescent (Go) human diploid fibroblasts exhibited very little inhibitory activity.
However, UV irradiation of Go cells, which is known to cause decondensation of chromatin,
significantly enhanced the inhibitory activity of extracts of these cells. These factors are termed
inhibitors of mitotic factors (IMF). They seem to be activated, rather than newly synthesized,
as the cell enters telophase when chromosomes begin to decondense. The IMF are nondi-
alyzable, nonhistone proteins with a molecular weight of >12,000. Since mitotic factors are
known to induce chromosome condensation, it is possible that IMF, which are antagonistic to
mitotic factors, may serve the reverse function of the mitotic factors, i.e ., regulation of
chromosome decondensation .
Chromatin undergoes profound structural alterations during
the cell cycle. During mitosis, it is supercoiled and condensed
to form the mitotic chromosomes. Chromosome condensa-
tion is a critical event in the cell cycle that is necessary for the
equal distribution of genetic material between the daughter
cells. The phenomenon of premature chromosome conden-
sation described by Johnson and Rao (13) has been very
useful in visualizing the state of chromatin condensation
during interphase. Using this technique, Rao and Hanks (30)
and Hanks and Rao (9) have shown that the process of
chromosome decondensation, initiated during the telophase
of mitosis, continues throughout the G, period until the
chromatin reaches its ultimate state ofdecondensation by the
end of G,, when DNA synthesis is initiated.
As for the factors involved in chromosome condensation,
studies from this and other laboratories have demonstrated
that when extracts from mitotic HeLa cells(39, 40) or mitotic
Chinese hamster ovary cells (19) are injected into Xenopus
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laevis oocytes, they exhibit maturation-promoting activity
(MPA)' as evidenced by germinal vesicle breakdown (GVBD)
and condensation of chromosomes. These studies also re-
vealed that the mitotic factors are nonhistone proteins and
accumulate slowly in the beginning of G2, increase rapidly
during late G2, and reach a threshold at the G2-mitotic tran-
sition when the chromatin is transformed into discrete chro-
mosomes (34, 38). The mitotic factors have great affinity for
chromatin and preferentially bind to it as soon as they are
synthesized in G2 phase; as the cell synthesizes more ofthese
factors in preparation for mitosis, increasing amounts ofthem
are retained in the cytoplasm (1). These chromosome-bound
mitotic factors can be released by mild digestion with endo-
nucleases (2).
' Abbreviations used in this paper:
￿
GVBD, germinal vesicle break-
down; IMF, inhibitors of mitotic factors; MPA, maturation-promot-
ing activity.
1707The objective of the present study was to investigate the
fate of mitotic factors as the cell divides and chromosomes
begin to decondense at telophase. Do the mitotic factors that
associate with chromatin during GZ and mitosis dissociate, or
are these factors inactivated in situ by some other factors
newly synthesized or activated as the cell divides? The results
ofthis study indicate the existence ofcertain factors (proteins)
during the G, period of mammalian cells that specifically
inactivate the mitotic factors as indicated by the loss of their
MPA when injected into oocytes. An abstract of this study
has appeared elsewhere (27).
MATERIALS AND METHODS
Chemicals
'H-L-amino acid mixture and '4C-L-amino acid mixture with identical L-
amino acid activities were obtained from New England Nuclear (Boston, MA).
2-Mercaptoethanol and Coomassie Brilliant Blue G-250 protein-binding dye
were purchased from Bio-Rad Laboratories (Richmond, CA). All other chem-
icals were of reagent quality and were mainly purchased from Sigma Chemical
Co. (St. Louis, Mo.).
Cells and Cell Synchrony
HE LA cEL Ls:
￿
HeLa cells were routinely grown as suspension cultures in
spinner flasks at 37°C in Eagle's minimum essential medium (Gibco Labora-
tories, Grand Island, NY) supplemented with 5% heat-inactivated fetal calf
serum (K C Biologicals, Inc., Lenexa, KS), sodium pyruvate, nonessential
amino acids, and penicillin-streptomycin mixture (Gibco Laboratories) in a
humidified 5% C02 atmosphere, as described earlier (28). These cells have a
cell cycle time of22 h, consisting ofa 10.5-h G, period, a 7.0-h S period, a 3.5-
h G2 period, and a 1-h mitosis (29).
To obtain mitotic cells, HeLa cells in exponential growth were plated in
1,585 cm2 borosilicate roller bottles (Bellco Glass Co., Vineland, NJ) as recently
described (2). Briefly, cells were partially synchronized into S phase by a single
excessthymidine (2.5 mM) block of20 h. After reversal ofthe thymidine block
by washing, cells were incubated in fresh medium containing Colcemid (0.05
ug/ml) (Ciba Pharmaceutical Co., Summit, NJ) for another 20 h at 37°C, and
mitotic cells were harvested by selective detachment.
To obtain a pure population of HeLa cells in S and G2 phases, we first
synchronized exponentially growing cells into S phase by the excess thymidine
double-block method (5, 29). Early-, mid-, and late-G2 cells were obtained by
harvesting cells at 8, 9, and 10 h after reversal ofthe second thymidine block
and incubation with Colcemid. Colcemid-arrested mitotic cells were removed
by selective detachment and discarded. The G2 cells that remained attached to
the surface were trypsinized and used for the experiments. The mitotic indices
in all these populations were never >3%.
HeLa cells synchronized in various stages of G, phase were obtained by
reversing the nitrous oxide-blocked mitotic cells as described previously (26).
Within 1.5 h after reversal of N20 block, >90% of the cells had completed
mitosis and entered G,.
W,-38 CELLS :
￿
A normal human diploid fibroblast cell line, WI-38, was
obtained from the American Type Culture Collection, Rockville, MD. These
cells were grown as monolayers in Lux plastic culture dishes in McCoy's 5A
medium (Gibco Laboratories) with 10% heat-inactivated fetal calf serum sup-
plementedwith glutamine and penicillin-streptomycin mixture in a humidified
C02 (5%) incubator at 37°C. Go cells were obtained by harvesting cells 7 d after
they had reached confluency.
UV Irradiation of Go Cells
The WI-38 Go cells were washed thoroughly with PBS (pH 7.2) before a 10-
s irradiation with a germicidal lamp emitting 90 ergs cm-' sec' at 254 nm
measured at the position ofthe cells. After UV irradiation, cells were incubated
in fresh medium in the presence or absence of DNA synthesis inhibitors
hydroxyurea (10-2 M) or arabinosylcytosine (10-4 M) for various times at 37°C
before being harvested. In experiments designed to determine ifUV irradiation
induced new protein synthesis or activatedexistingproteins, cycloheximide (25
ug/ml) was added at the time of irradiation and kept in the medium during
posttreatment incubation.
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Preparation of Cytoplasmic, Nuclear, and
Chromosomal Extracts
Cells synchronized in various phases were collected at 4°C by centrifugation
at 1,000 rpm for 5 min. After three washings with Eagle's minimum essential
medium without serum at 4°C, the cytoplasmic, nuclear, or chromosomal
extracts were prepared as described previously (1, 2). Briefly, cells were lysed in
a modification of the buffer of Blumenthal et al. (4), buffer A: 15 mM Tris-
HCI, pH 7.4, containing 60 mM KCI, 15 mM NaCl, 0.5 mM spermidine, 0.15
mM spermine, 15 mM 2-mercaptoethanol, 2 mM EDTA, 0.5 mM EGTA,
supplemented with the protease inhibitor 1 mM phenylmethylsulfonyl fluoride,
the phosphatase inhibitors l mM ATP, 5 mM NaF, and 5 mM sodium 0-
glycerolphosphate, and 0.25 M sucrose. After centrifugation the chromosomal
or nuclear pellet was washed once again with the same buffer and then
resuspended in the high-salt buffer B: 10 mM Na2HPO,/NaH2PO4, 200 mM
NaCl, 2 mM EGTA, 10 MM MgS04, 1 mM ATP, l mM phenylmethylsulfonyl
fluoride, 5 mM NaF, 5 mM sodium 0-glycerolphosphate and 0.25 M sucrose
at pH 6.5, to extract a subset of nonhistone chromatin-binding proteins. The
cytoplasmic, nuclear, or chromosomal extracts were further centrifuged at
100,000g for 1 h in aTI 50rotorin a Beckman L5-50 ultracentrifuge (Beckman
Instruments, Inc., PaloAlto, CA). The pellets were discardedand aliquots from
the resulting clear supernatants were injected into Xenopus laevis oocytes to
determine their MPA. For some whole-cell extracts, cells were suspended in
buffer B and lysed by sonication (3 x 10 s) and then centrifuged at 100,000 g.
The extracts were always stored at -70°C until further use.
Preparation of Xenopus Laevis Oocytes and Assay
for Maturation Promoting Activity
All the procedures employed for the preparation of oocytes and assay ofthe
cell extracts for MPA by microinjection into oocytes were essentially the same
as described earlier (1, 2). The presence or absence of the germinal vesicle for
thequestionable oocytes wasalsodetermined by fixation in 7.5% trichloroacetic
acid and subsequent dissection of the oocyte before scoring for GVBD induc-
tion. Forevery set ofoocytes removed from Xenopus, a batch was always tested
for normal maturation by stimulation with progesterone (10 ug/ml) for 15 min
and incubated for -V8 h before scoring for GVBD induction. As a further
control, for every series of injections with extracts, about 10 oocytes were
injected with extraction buffer.
Determination of the Protein Content
The protein concentration was determined by the use of a Coomassie
Brilliant Blue G-250 dye-binding assay according to Bradford (6), using BSA
as the standard.
Treatment of G, Cell Extracts
All treatments to study the effect of proteases, RNase, chelating agents,
temperature, and pH on G, factors were performed on freshly prepared early-
G, cell extracts before they were mixed with mitotic extracts in various
proportions and eventually injected into oocytes to determine their MPA.
Control experiments were simultaneously performed on mitotic extract diluted
with extraction buffer.
RESULTS
The Fate of Mitotic Factors during Mitosis
to G, Transition
To determine whether G, cells contained factors that could
inactivate the mitotic factors at the end of mitosis, mitotic
cell extracts were mixed with G, cell extracts in different
proportions and the mixtures were injected into oocytes to
test for MPA (Fig. 1). Mitotic cell extracts diluted with ex-
traction buffer in corresponding proportions served as con-
trols. It is evident from Fig. 1 that the mitotic cell extract
could be diluted with the extraction buffer down to a 20%
concentration without any significant loss of MPA. However,
when the mitotic cell extract was mixed with the G, cell
extract, we noticed a rapid inactivation of the mitotic factors
even at mitotic extract concentration as high as 66.6% . In100
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FIGURE 1
￿
Effect of G, cell extracts on the MPA of the mitotic cell
extracts . HeLa cells in G, phase were collected at different times
(i.e ., at 1 .5, 2, 3, 4, 5, 6, 7, and 7 .5 h) after reversal of the N 20
block . G, cell extracts were made using 6-8 x 10' cells/ml with a
protein content ranging from 8-11 mg/ml . Similarly, mitotic cell
extracts were made using 4 x 10' cells/ml containing ^-8 mg/ml of
protein . Whenever necessary, extracts were concentrated to give a
protein content of 8 mg/ml by ultrafiltration using Amicon YM-10
filters . Extracts of G, cells at different points during G, were sepa-
rately mixed with mitotic extracts in various proportions so as to
obtain a mitotic extract concentration of 100, 75, 66.6, 50, 33 .3,
25, 20, 10, and 0% in the injection mixture . These mixtures were
incubated for 1 h at 4°C prior to injection into Xenopus oocytes .
For each dilution a minimum of 10 oocytes was injected . A volume
of 65 nl (containing ^-50-550 ng of proteins) was usually injected.
The percentage of GVBD in the injected oocytes was determined
at 2-3 h after injection by scoring the oocytes for the appearance
of a white spot in the animal hemisphere . In doubtful cases oocytes
were fixed in 7.5% trichloroacetic acid and dissected to check for
the breakdown of the germinal vesicle . Mitotic cell extracts diluted
with the extraction buffer (in the presence or absence 10 mg/ml of
bovine serum albumin) to give corresponding concentrations served
as controls . These data represent an average of five experiments
and the differences in % GVBD between the experiments did not
exceed 10% . Typically oocytes from the same female were used
for a given experiment . Dilution of mitotic extract with extracts
from G, cells at 1 .5 h, O, 2 h, O, and 7 .5 h, 0, after reversal of the
N 20 block . Dilution with buffer, 41 . The data obtained with extracts
from G, cells collected at 3, 4, 5, 6, or 7 h after reversal were
identical to those of G, cells at 2 h, and hence these data are not
presented .
general, when mitotic and G, cell extracts with equal protein
content were mixed, a complete inactivation of the mitotic
cell extract occurred as its concentration was reduced to 50% .
These experiments were repeated several times with highly
reproducible results . As another control we added 10 mg/ml
of BSA as a carrier protein to the extraction buffer before
mixing with the mitotic extracts and observed no inactivation
of the mitotic factors even at concentrations as low as 20%,
as in the case of regular buffer control,
Extracts from HeLa G, cells collected at any time from 2
to 7 h after reversal of the nitrous oxide block were very
effective in inactivating the mitotic factors . Cells collected at
later times had decreased activity (Fig . 1) . Furthermore, these
inactivating factors were detectable as early as 1 .5 h after
reversal of the N 20 block when 10-15% of the cells were yet
to complete mitosis . These data suggest that there are certain
factors in G, cells that inhibit the MPA of the mitotic cell
FIGURE 2 Inactivation
of mitotic factors as a
function of protein con-
centration in the G, cell
extract . Early G, phase
HeLa cells were ob-
tained at 3 h after re-
versal of the N 20 block .
G, cell extracts with
various protein con-
centrations (^-4-16
mg/ml) were prepared
by varying the cell
GI/M Protein Ratio
￿
number while keeping
the volume of the extraction buffer constant . Protein content of the
mitotic cell extracts was kept constant by taking 4 x 10' cells/ml
(^ "8 mg/ml) throughout these studies . Aliquots of G, cell extracts
with Various protein concentrations in relation to that of mitotic
extract, i.e ., 0.5, 1 .0, 1 .5, and 2 .0, were separately mixed with
mitotic extracts in various proportions and tested for MPA as
described in the legend for Fig . 1 .
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extracts and we have termed them inhibitor(s) of mitotic
factors (IMF) .
Inactivation of Mitotic Factors by IMF
is Dose Dependent
By increasing the protein content in G, extracts, inactiva-
tion ofthe mitotic extract could be obtained at lower dilutions
(Fig . 2). The higher the G I protein content the lower the
amount of G I extract needed to completely inactivate the
mitotic factors, provided the concentration ofmitotic proteins
was kept constant .
Presence of IMF during S Phase ofHeLa Cells
To determine whether the inhibitors of mitotic factors are
present during other phases of the cell cycle, similar studies
were carried out with extracts ofHeLa cells synchronized in
different stages of S and G2 . When extracts from early-,
mid-, and late-S phase cells were mixed with mitotic extracts
and then injected into oocytes to test for MPA, we observed
that each of these S phase extracts did not neutralize the
mitotic factors but delayed GVBD by 4.5 h . The method of
synchronization into S phase (by reversal ofsecond thymidine
block or reversal of N20 block) or of harvesting cells (by
trypsinization or scraping) did not make any difference . How-
ever, increasing the protein concentration of the S phase
extracts threefold (by taking more cells in the same volume
of extraction buffer) increased the inhibitory activity ofthese
extracts . Extracts from early S phase cells were more effective
in neutralizing the activity of the mitotic factors than those
from either mid- or late-S phase cells (Fig . 3) . No significant
IMF activity was observed in late-S phase cell extracts even
when S phase/mitotic cell protein ratio was increased to 5:1 .
Extracts from early-, mid-, or late-G 2 phase HeLa cells also
had no inhibitory effect on the mitotic factors .
Activation of IMF in Quiescent (Go )
WI-38 Human Fibroblasts
Extracts of WI-38 cells collected 7 d after they had reached
confluency were mixed with extracts of mitotic HeLa cells in
various proportions as explained above and the mixtures were
injected into oocytes to test forMPA . Extracts from quiescent
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FIGURE 3 Effect of S phase cell extracts on the MPA of mitotic
extracts . HeLa cells were synchronized in S phase as described
under Materials and Methods . Early-, mid-, and late-S phase cells
were collected at 2, 4, and 6 h, respectively, after reversal of the
second thymidine block . Extracts from these S phase cells were
prepared using 12-15 x 10' cells/ml, with a protein concentration
of 22-27 mg/ml, whereas the mitotic extract was prepared by using
4 x 10' mitotic cells/ml, with -8 mg/ml of protein, thus giving an
S-phase/mitotic protein ratio of 3 :1 . Aliquots from each of these S
phase extracts were separately mixed with mitotic extracts in var-
ious proportions and mixtures were injected into oocytes to test for
MPA as explained in the legend to Fig. 1 . ", dilution with buffer
(negative control) ; O, dilution with mid- G, cell extract as in Fig. 1
(positive control); dilution with extracts from early, ", mid-, El, and
late, Z~, S phase cells .
X
C
m
100
so
80
40
20
0
100 80 80 40 20 0
% Mitotic Extract In Injection Mixture
FIGURE 4
￿
Activation of IMF in quiescent (Go ) WI-38 human diploid
fibroblasts by UV irradiation . WI-38 cells inGo phase were collected
at 7-10 d after they had reached confluency . G o cells were UV-
irradiated for 10 s at 90 ergs CM-2 sec- ' and incubated for various
times in the presence or absence of cycloheximide (25 pg/ml),
arabinosylcytosine (10-° M), or hydroxyurea (10-z M) . Extracts from
the control and treated Go cells were prepared so as to contain a
protein concentration equal to that of mitotic extracts (^ " 8 mg/ml) .
Extracts of G o cells from the different treatments were separately
mixed with mitotic extracts and tested for MPA as in Fig . 1 legend .
" , dilution with buffer (negative control) ; O, dilution with mid G,
cell extract (positive control); 0, extracts from untreated G o cells
pretreated with Ara-C and hydroxyurea; extracts from Go cells, UV-
irradiated and incubated in the presence or absence of cyclohexi-
mide for 2 h (CI) ; and 4 h (/) ; extracts from Go cells, UV-irradiated
and incubated for 2 h in the presence of Ara-C and hydroxyurea
(A) . The data presented here are an average of two experiments .
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cells exhibited minimal inhibitory effects on mitotic factors .
However, UV irradiation (which is known to induce chro-
mosome decondensation and unscheduled DNA synthesis [7,
12, 36]) of Go cells, and subsequent incubation for 2-4 h
increased the inhibitory activity of extracts from these cells
(Fig . 4) . The presence of cycloheximide during incubation
had no effect on IMF activity . IMF activity was further
enhanced if hydroxyurea and arabinosylcytosine were added
during incubation after UV irradiation .
Activation of IMF at Mitosis-G, Transition
To determine whether the IMF were newly synthesized or
were pre-existing factors activated at the M-G, transition, we
synchronized HeLa cells in mitosis by the NCO block method
and allowed them to divide in the presence or absence of
cycloheximide . At 3 h after reversal ofthe mitotic block, when
>95% of the cells were in G,, extracts were made from the
control and cycloheximide-treated cultures, separately mixed
with mitotic extracts in various proportions, and tested for
MPA . The extracts from cells that were allowed to divide in
the presence of cycloheximide were as inhibitory as those
from the control G, cells (data not shown) . These experiments
indicate that the IMF are not newly synthesized but rather
are activated at the time of cell division .
Preliminary Characterization of the IMF
Our earlier studies (1, 2, 40) have shown that the mitotic
factors ofHeLa cells are highly sensitive to Ca" . These factors
are completely inactivated in the presence of 1 mM Ca2+. It
is, therefore, possible that the inactivation of mitotic factors
at the end of mitosis could be due to an excess release of
calcium into the cytoplasm . To rule out this possibility two
sets of experiments were performed . In the first set, a freshly
prepared G, cell extract was titrated with increasing concen-
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FIGURE 5
￿
Effect of chelating agents on the IMF activity . Extracts
from early-G, HeLa cells were prepared as described in legends to
Figs . 1 and 2 and incubated for 1 h at 4°C with various concentra-
tions of EGTA or EDTA (1 mM-5 mM) . These EGTA- or EDTA-
treated G, cell extracts were separately mixed with extracts from
mitotic HeLa cells and tested for MPA as described in the legend
to Fig. 1 . " , buffer (negative control) ; O, HeLa G, cell extracts
(positive control) ; O, buffer containing 5 mM EGTA or EDTA; 0,
HeLa G, cell extracts incubated with 1, 2, 3, or 4 .mM EGTA or
EDTA prior to being mixed with mitotic extracts; ", HeLa G, cell
extracts incubated with 5 mM EGTA or EDTA . These data represent
an average of two experiments .TABLE I
Preliminary Characterization of IMF
" Afreshly prepared mid-G, cell extract from 8 x 107 cells/ml wasmixed with
mitotic extract from 4 x 107 cells/ml to give a mitotic/G, protein ratio of
1 :1, and the mixture was injected into Xenopus laevis oocytes for MPA
determination. A mixture of mitotic extract with extraction buffer served as
control. If the G, cell extract completely inactivated the MPA of the mitotic
extract at a 50%dilution, i.e., a protein ratio of 1:1, then the activity of the
G, cell extract was considered to be 100%. An average of 10 oocytes was
injected for each sample.
# G, cell extract was treated with the protease papain (500 ug/ml) in extraction
buffer containing cystein (5 mM) and ,B-mercaptoethanol (0.05 mM) for 1 h
at 25 ° C. Antipain (80ug/ml) was then added for 15 min at 25°C to neutralize
the excess papain before being mixed with mitotic extract in various
proportions and eventually injected into oocytes for MPAdetermination. In
these experiments we made certain that papain activity was completely
neutralized by antipain so that it could not inactivate the mitotic factors,
which are known to be proteins.
s G, cell extracts were incubated with RNase (1 .5 U/ml) at 25°C for 1 h. At
the end of incubation, G, extracts were mixed with mitotic extracts and
tested for MPAas above.
G, cell extracts were incubated at different temperatures for 15 min andat
the end of the incubation extracts were centrifuged at 10,000 gfor 15 min
at 4°C to remove any precipitate before being mixed with mitotic extract
for injection into oocytes.
n G, cell extracts were dialyzed overnight against buffers of different pH with
three changes each and redialyzed for 12 h against the extraction buffer
(pH 6.5) before the mixing experiments were carried out to test the activity,
as explained above.
trations of the Ca=+-chelating agent EGTA before the mixing
experiments with mitotic extracts were performed. In control
experiments, the mitotic cell extract was treated with identical
concentrations of EGTA and tested for MPA. The difference
between the inhibitory activities ofthe control and the EGTA-
treated G, cell extracts was insignificant (Fig. 5). Similar
results were obtained when EDTA instead ofEGTA was used.
In the second set of experiments, G, cell extract was dialyzed
through a bag with a cut-off limit of either 3,500 or 12,000
mol wt with a buffer lacking Ca2', EDTA, or EGTA. Dialysis
had no effect on the inhibitory activity of the G, cell extract
when it was later mixed with mitotic cell extract (data not
shown).
Effect of Proteases and RNase
To test whether the activity of IMF was protease sensitive,
the G, cell extract was incubated with a protease, Papain or
trypsin, for 1 h at 25°C. Antipain or trypsin inhibitor was
then added to neutralize the excess protease before mixing it
with the mitotic cell extracts. As shown in Table I, treatment
with papain resulted in complete inactivation ofthe inhibitors
of mitotic factors. Control experiments performed showed
that the amount of antipain used was enough to inhibit all
papain activity. Injection of extraction buffer containing pa-
pain or antipain did not show any MPA.
Treatment ofG, cell extract with RNase (1 .5 U/ml) at 25°C
for 1 h before performing the mixing experiments did not
result in any inactivation of these factors (Table 1). We have
already shown that RNase has no effect on the MPA ofmitotic
factors (40). RNase at the concentration tested was not toxic
to oocytes and did not induce any GVBD when injected
alone.
Effect of Temperature
Incubation of the G, extract at temperatures up to 65°C for
15 min had no effect on the IMF activity (Table 1). At 75°C
for 15 min, a slight precipitation and a 25% loss in the activity
of these factors was observed. At 100°C for 15 min, these
factors were completely inactivated.
Effect ofpH
The IMF were found to be active over a broad range ofpH,
and the pH optimum was found to be between 7 and 8. Very
little activity was seen below pH 5 (Table I). These properties
clearly distinguish the IMF from mitotic factors, which seem
to be more stable at low pH.
DISCUSSION
In this study, we have attempted to determine the fate of the
chromosome-bound mitotic factors at the end of mitosis. We
have demonstrated the existence ofcertain factors in G, cells
that can inactivate or inhibit the mitotic factors and that have
tentatively been named inhibitors of mitotic factors (IMF).
The bioassay system for IMF involves the mixing of extracts
from interphase (G,, S, or GZ) HeLa cells with mitotic cell
extracts in various proportions and injecting the mixture into
immature Xenopus oocytes to determine the extent of inacti-
vation of the mitotic factors as indicated by a decrease in the
frequency of GVBD among the injected oocytes. Mitotic
extracts diluted with the extraction buffer (with or without
BSA) in corresponding proportions served as controls. This
method of measuring IMF activity, though indirect, should
be useful for the isolation and characterization ofthese factors.
Using this assay, we have shown that the levels of IMF
fluctuate during the cell cycle in a cyclical pattern. These
factors are activated at telophase, when the process of chro-
mosome decondensation begins, and are present at relatively
high levels throughout the G, period. There appears to be an
inverse linear relationship between the protein content of the
G, cell extracts and the dilution ratio of mitotic/G, phase
extracts at which mitotic factors are inactivated (Fig. 2). These
factors reach their minimum level during S phase and are
absent during G2 phase, when mitotic factors are known to
accumulate (1, 39).
The preliminary characterization of the IMF reported here
suggests that these factors are nondialyzable, nonhistone pro-
teins sensitive to inactivation by proteases, but not by RNase,
EGTA, or EDTA . It is unlikely that the IMF activity could
be due to a protease as three different protease inhibitors
(phenylmethylsulfonyl fluoride, antipain, and trypsin inhibi-
tor) used in our study had no effect on IMF activity. Unlike
the mitotic factors, IMF are heat stable (15 min at 65°C).
They are stable over a broad pH range (6.0-10.0) but are
extremely sensitive to low pH (below 5.0), and the apparent
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Treatment of G, cell extract Relative IMF activity
None 100
Papain* 0
RNase§ 100
Temperatures
0°C for 2 d 80
-70°C for 2 mo 100
25-65°C for 15 min 100
75°C for 15 min 75
100°C for 15 min 0
pH'
4.0 20
5.0-5 .5 75
6.0-8.0 100
8.5-10.0 75-80molecular weight is >12,000. Some of these characteristics
distinguish them from the mitotic factors (40). The pH de-
pendency ofthese factors is also in agreement with the results
of the early cell fusion experiments of Obara and co-workers
(21-23), which suggested that high pH favored "telophasing"
and low pH "prophasing" or premature chromosome conden-
sation. Our own studies (Hittelman and Rao, unpublished
data) show that the frequency of premature chromosome
condensation induction is much higher if a low pH is main-
tained during the collection of mitotic cells and subsequent
fusion procedures. Thus, it appears that at low pH, the mitotic
factors are active, whereas the G, factors are either inactive
or less active.
The existence of a chromosome condensation cycle within
the life cycle ofmammalian cells was first proposed by Mazia
(16) and has subsequently been substantiated by various
investigators using different experimental approaches (8-11,
17, 18, 20, 24, 25, 30, 33, 35-37, 41, 42). According to these
studies the decondensation of chromatin takes place through-
out G, and until the beginning of S phase, at which time
DNA replication is initiated. Following replication, the chro-
matin recondenses during late S and G2 periods and reaches
a maximum level of condensation at mitosis in the form of
chromosomes. Regulation of this sequence of events by cy-
toplasmic factors has been suggested by the experiments of
Rao and Johnson (32) and Johnson and Rao (13). Using the
technique of premature chromosome condensation, they have
shown that chromosome condensation factors are present in
mitotic cells (14, 31).
Subsequently, we have shown that microinjection of mitotic
extracts into Xenopus oocytes causes meiotic maturation, i.e.,
GVBD and chromosome condensation, a process similar to
premature chromosome condensation (39). Using this system
we have demonstrated that the mitotic factors are nondialyz-
able, heat- and Cat'-sensitive, magnesium-dependent, non-
histone chromatin-binding proteins with an approximate mo-
lecular weight of 100,000 (1, 2, 40).
The accumulation of mitotic factors during G2 and mitosis
(1, 2, 39, 40) is closely correlated with a progressive increase
in the chromosome condensation. During metaphase, when
the chromosomes are most condensed, the levels of mitotic
factors are the highest. What happens to the mitotic factors
at the end of mitosis? The results of this study suggest that
certain factors (proteins) are activated at the mitosis-G, tran-
sition that inactivate the mitotic factors in situ. The IMF are
present throughout G, and the early part of S phase in HeLa
cells. Furthermore, our recent in vitro studies with IMF and
mitotic factors suggest that the IMF specifically inactivate the
mitotic factors probably by binding to their active site and
forming an inert complex (3).
As mentioned earlier, the fusion of a mitotic cell with an
interphase cell results in a rapid chromosome condensation
and the dissolution of the nuclear envelope of the interphase
cell within 45 min after fusion. This phenomenon has been
termed premature chromosome condensation (14) or "pro-
phasing" (15). The ability ofa mitotic cell to induce premature
chromosome condensation in an interphase nucleus depends
largely on the ratio of mitotic to interphase nuclei in the cell
at the time of fusion. Very low frequency or no induction of
premature chromosome condensation was observed in tri-, or
tetranucleates containing one mitotic and two or three G,
nuclei (14). Furthermore. Obara and co-workers (21-23) have
reported that in certain cases in these multinucleate cells
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containing higher ratio of interphase cells, a membrane is
formed around the metaphase chromosomes. Because of its
resemblance to the process occurring in normal telophase,
this process has been termed "telophasing" (21-23). They
have also demonstrated that the larger the ratio of interphase
nuclei to chromosomes in the fused cells the greater the
possibility that "telophasing" would occur rather than pro-
phasing. Moreover, we have observed that if the mitotic cells
are held for a prolonged period in Colcemid, their ability to
induce premature chromosome condensation in interphase
cells is greatly diminished (unpublished observations). The
present study seems to provide an explanation for the failure
of mitotic cells to induce premature chromosome condensa-
tion in multinucleate cells when the interphase to mitotic
ratio is >2.
Our data reported here indicate that the IMF are activated
at telophase and are present throughout G, period thus coin-
ciding with the process ofchromosome decondensation which
is known to begin at telophase and continue throughout G,
phase. It is tempting to speculate that the IMF which are
antagonistic to mitotic factors may serve the reverse function
of the mitotic factors, i.e., if the mitotic factors are involved
in chromosome condensation, the IMF may be involved in
chromosome decondensation. This proposition is further
strengthened by the following observations: (a) Noncycling
Go phase human fibroblasts, in which the chromatin is more
condensed than in cycling G, cells (9), contain little or no
IMF (Fig. 4). However, IMF can be activated in these cellsby
UV irradiation which causes chromosome decondensation
and DNA repair synthesis (7, 12, 36). (b) We have recently
observed that the UV-induced chromosome decondensation
in mitotic HeLa cellsis associated with inactivation of mitotic
factors and the induction of IMF (3). (c) In cell fusion exper-
iments, Rao and Johnson (32) and Rao et al. (33) observed
that the entry of G2 cells into mitosis is delayed after fusion
with G, or S phase cells until G, or S phase nuclei in the
heterophasic binucleate cells have completed DNA synthesis
and subsequently both nuclei have entered mitosis synchro-
nously. They speculated that the G, and S phase components
were causing decondensation of chromatin in G2 nuclei, thus
blocking them from entering mitosis. The present study seems
to provide experimental evidence to support that assumption.
Taken together, all these observations suggest that IMF may
play a role in the regulation of chromosome decondensation.
However, a direct relationship between IMF and chromosome
decondensation remains to be established.
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